Lederer & Associates Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.92M | Sell |
5,291
-608
| -10% | -$208K | 1.26% | 25 |
|
|
2026
Q1 | $2.08M | Sell |
5,899
-741
| -11% | -$264K | 1.47% | 23 |
|
|
2025
Q4 | $2.17M | Sell |
6,640
-43
| -0.6% | -$13.6K | 1.46% | 19 |
|
|
2025
Q3 | $1.89M | Sell |
6,683
-175
| -3% | -$50.8K | 1.22% | 25 |
|
|
2025
Q2 | $1.92M | Sell |
6,858
-36
| -0.5% | -$10.2K | 1.27% | 23 |
|
|
2025
Q1 | $2.15M | Sell |
6,894
-50
| -0.7% | -$14.8K | 1.57% | 18 |
|
|
2024
Q4 | $1.81M | Sell |
6,944
-15
| -0.2% | -$4.45K | 1.26% | 23 |
|
|
2024
Q3 | $2.24M | Sell |
6,959
-94
| -1% | -$30.7K | 1.58% | 15 |
|
|
2024
Q2 | $2.2M | Sell |
7,053
-350
| -5% | -$103K | 1.59% | 15 |
|
|
2024
Q1 | $2.1M | Sell |
7,403
-1,731
| -19% | -$507K | 1.46% | 19 |
|
|
2023
Q4 | $2.63M | Sell |
9,134
-213
| -2% | -$58K | 1.95% | 12 |
|
|
2023
Q3 | $2.51M | Sell |
9,347
-73
| -0.8% | -$18.2K | 2% | 10 |
|
|
2023
Q2 | $2.09M | Sell |
9,420
-28
| -0.3% | -$6.5K | 1.58% | 17 |
|
|
2023
Q1 | $2.28M | Sell |
9,448
-88
| -0.9% | -$21.6K | 1.76% | 14 |
|
|
2022
Q4 | $2.5M | Sell |
9,536
-332
| -3% | -$89K | 2.05% | 10 |
|
|
2022
Q3 | $2.22M | Sell |
9,868
-171
| -2% | -$41.5K | 1.88% | 12 |
|
|
2022
Q2 | $2.44M | Sell |
10,039
-1,356
| -12% | -$332K | 1.88% | 11 |
|
|
2022
Q1 | $2.76M | Sell |
11,395
-152
| -1% | -$34.9K | 1.69% | 16 |
|
|
2021
Q4 | $2.6M | Sell |
11,547
-134
| -1% | -$28.3K | 1.51% | 20 |
|
|
2021
Q3 | $2.48M | Buy |
11,681
+1,616
| +16% | +$372K | 1.6% | 22 |
|
|
2021
Q2 | $2.45M | Sell |
10,065
-215
| -2% | -$52.9K | 1.63% | 21 |
|
|
2021
Q1 | $2.56M | Buy |
10,280
+41
| +0.4% | +$9.78K | 1.8% | 17 |
|
|
2020
Q4 | $2.35M | Sell |
10,239
-74
| -0.7% | -$17.1K | 1.81% | 19 |
|
|
2020
Q3 | $2.62M | Buy |
10,313
+44
| +0.4% | +$10.9K | 2.18% | 8 |
|
|
2020
Q2 | $2.42M | Sell |
10,269
-65
| -0.6% | -$14.8K | 2.26% | 12 |
|
|
2020
Q1 | $2.1M | Buy |
10,334
+163
| +2% | +$35.6K | 2.37% | 11 |
|
|
2019
Q4 | $2.45M | Sell |
10,171
-2,569
| -20% | -$566K | 2.13% | 11 |
|
|
2019
Q3 | $2.46M | Sell |
12,740
-325
| -2% | -$62.4K | 2.36% | 10 |
|
|
2019
Q2 | $2.41M | Buy |
13,065
+400
| +3% | +$71.6K | 2.21% | 8 |
|
|
2019
Q1 | $2.41M | Sell |
12,665
-105
| -0.8% | -$20.1K | 2.24% | 9 |
|
|
2018
Q4 | $2.49M | Sell |
12,770
-380
| -3% | -$74.1K | 2.66% | 5 |
|
|
2018
Q3 | $2.73M | Buy |
13,150
+310
| +2% | +$61.1K | 2.3% | 8 |
|
|
2018
Q2 | $2.37M | Sell |
12,840
-325
| -2% | -$57.5K | 2.14% | 9 |
|
|
2018
Q1 | $2.24M | Sell |
13,165
-141
| -1% | -$25.9K | 2.02% | 10 |
|
|
2017
Q4 | $2.31M | Buy |
13,306
+277
| +2% | +$49K | 2.07% | 14 |
|
|
2017
Q3 | $2.43M | Buy |
13,029
+41
| +0.3% | +$7.26K | 2.32% | 8 |
|
|
2017
Q2 | $2.24M | Buy |
12,988
+695
| +6% | +$113K | 2.16% | 10 |
|
|
2017
Q1 | $2.02M | Buy |
12,293
+130
| +1% | +$21.6K | 1.89% | 17 |
|
|
2016
Q4 | $1.78M | Buy |
+12,163
| New | +$1.83M | 1.76% | 25 |
|
|
2015
Q3 | $1.54M | Buy |
+11,110
| New | +$1.75M | 1.71% | 25 |
|
Other funds holding AMGN
FFM
SP
Lederer & Associates Investment Counsel's AMGN Position: Q2 2026 in Review
Lederer & Associates Investment Counsel reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $208K and leaving 5,291 shares worth $1.92M. The position accounts for 1.26% of the portfolio, ranked #25.
Lederer & Associates Investment Counsel first reported a position in AMGN in Q3 2015 and has held it in 40 quarters since. The position peaked at $2.76M in Q1 2022. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Lederer & Associates Investment Counsel held 5,291 shares of Amgen worth $1.92M as of Q2 2026.
- Lederer & Associates Investment Counsel sold 608 Amgen shares in Q2 2026, an estimated $208K.
- Amgen made up 1.26% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #25 holding.
- Lederer & Associates Investment Counsel first reported a position in Amgen in Q3 2015 and has held it in 40 quarters since.
- Lederer & Associates Investment Counsel's Amgen position peaked at $2.76M in Q1 2022.
- 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.